fda approval status bpc-157 tb-500 cjc-1295 ipamorelin First of all, it's important to understand that the July panel meeting is not even the final step in getting some of these peptides back to category 1 for compounding. This panel BPC-157/TB-500 10mg/10mg - FITSKNS Peptides

Food and Drug Administration's Pharmacy Compounding Advisory Committee reviewed AOD-9604 alongside other unapproved peptides and recommended against allowing the compound to be used in 503A pharmacy compounding

Conversely, a few studies reported high levels of vitamin B12 in the blood of patients with a worse COVID-19 outcome 48,49 potentially due to cytolysis leading to the release of intracellular B12 into the plasma and disrupted B12 clearance by the liver, which is often affected in these patients 50

The remaining 70mg stays as powder until you're ready for your next batch

AOD-9604 AOD-9604, a synthetic peptide fragment derived from the C-terminal region of human growth hormone (HGH), specifically amino acids 176-191